| Volume | 175 |
| Open | 25.79 |
| Bid (Size) | 13.79 (200) |
| Ask (Size) | 38.89 (200) |
| Prev. Close | 25.92 |
| Today's Range | 25.79 - 25.79 |
| 52wk Range | 23.15 - 27.94 |
| Shares Outstanding | 1,300 |
| Dividend Yield | 1.60% |
Amplify Weight Loss Drug & Treatment ETF (THNR) traded between $23.15 and $27.94 over the past 52 weeks and last traded at $25.79, 7.7% below its 52-week high. Over the past week it ranged between $24.01 and $26.01.
THNR was +11.0% over the past year, +4.5% over six months, +1.5% year to date, +4.7% in the last week.
Over the past 12 months THNR returned +11.0% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.4%, QQQ (Nasdaq 100) +8.4% and IWM (Russell 2000) +14.0%.
THNR most recently traded 175 shares against a 3-month average daily volume of 1.2K.